Brightsight is the largest independent security evaluation lab in the world, with eleven licensed labs in Delft (NL), Barcelona and Madrid (SP), Meyreuil (FR), Graz (AU), Beijing, Shanghai and Guangzhou (CN), Singapore, and Clackamas and Columbia (USA).
Intellectual Property Statement
Except where expressly stated otherwise, all intellectual property rights, including copyright and trademarks, in any and all communications and materials in any form published by or on behalf of SGS are owned by SGS Société Générale de Surveillance SA, Switzerland.
EyeSense was founded in 2006 as a spin-off of CIBA Vision, a subsidiary of the Novartis Group. Clinical trials with the first prototypes of an eye sensor were successfully conducted as early as 2007. Since 2010, development efforts have been focussed on the development of the FiberSense platform. The first product on this platform is the FiberSense CGM for continuous glucose monitoring. The application for marketing authorisation has already been submitted.